Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06480552 |
| Title | An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Teva Branded Pharmaceutical Products R&D, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Teva Investigational Site 12016 | RECRUITING | Chicago | Illinois | 60611 | United States | Details |
| Teva Investigational Site 12015 | RECRUITING | Detroit | Michigan | 48201 | United States | Details |
| Teva Investigational Site 12014 | RECRUITING | Huntersville | North Carolina | 28078 | United States | Details |
| Teva Investigational Site 12058 | RECRUITING | Pittsburgh | Pennsylvania | 15232 | United States | Details |
| Teva Investigational Site 12019 | RECRUITING | Nashville | Tennessee | 37203 | United States | Details |
| Teva Investigational Site 12018 | RECRUITING | Fairfax | Virginia | 22031 | United States | Details |